Contact the Drugs API provider to receive precise data for fetching general information on drugs and similar purposes easily. Drugs API by Drugbank offers extensive and essential elements required for healthcare marketing, pharmaceutical comparison and analysis, providing information about drugs on healthcare platforms, healthcare research and more related projects.
Menu
Clinical Trial Studies API
Clinical trial studies API for fetching all content for a small set of study records
The Clinical Trials clinical trial studies API has data for fetching all content for a small set of study records. A few use cases for the full clinical trial studies API are for example; providing research text on clinical trials for medicine-related platforms, mobile applications, websites, research and more. It is ofcourse possible that clients have different use cases which haven’t been thought of previously. It would be interesting to read about these. With this system you are able to filter determined by fmt, expr, min_rnk, max_rnk, fields and field to get the response output you would like. Some examples of the type of business who uses it are healthcare and medicine platforms, researchers in medicine field and more, typically the clients are small business, medium business and enterprises in the healthcare, medicine and pharmaceutical industry. This database has coverage in the US.
Menu
Clinical Trial Studies API endpoints
| GET |
| /api/query/full_studies |
| GET | /api/query/full_studies |
In order to receive a data response like in the example output, clients need to communicate with the clinical trial studies API endpoint by sending a GET data request to the endpoint; /api/query/full_studies with the right object parameters. All main programming languages function with the data output. You simply need to attach the private API key as an endpoint parameter and you will begin receiving data. Place the API endpoint in the URL to apply for the data request. The object and description table demonstrates the appropriate objects and parameters response descriptions.
Filtering methods for clinical trial studies data
See below the filters applicable with the clinical trial studies data.
| Filters | ||
fmt |
field |
|
expr |
|
|
min_rnk |
|
|
max_rnk |
|
|
fields |
|
Clinical trial studies API data description
Find the objects and their associated description using the table to be able to make use of the system also make use of the available parameters to be able to receive the required response output.
| Objects | Description |
Rank | |
Study | |
ProtocolSection | |
IdentificationModule | |
NCTId | |
OrgStudyIdInfo | |
OrgStudyId | |
SecondaryIdInfoList | |
SecondaryIdInfo | |
SecondaryId | |
SecondaryIdType | |
SecondaryIdDomain | |
Organization | |
OrgFullName | |
OrgClass | |
BriefTitle | |
OfficialTitle | |
Acronym | |
StatusModule | |
StatusVerifiedDate | |
etc | etc |
Clinical trial studies API response output
Here is an example output response of the endpoint request. There is more data available, this example is limited to be able to make it readable. Subscribe to the API and receive the full response output.
{
"FullStudiesResponse":{
"APIVrs":"1.01.05",
"DataVrs":"2022:11:17 23:33:37.354",
"Expression":"heart attack",
"NStudiesAvail":433955,
"NStudiesFound":9364,
"MinRank":1,
"MaxRank":1,
"NStudiesReturned":1,
"FullStudies":[
{
"Rank":1,
"Study":{
"ProtocolSection":{
"IdentificationModule":{
"NCTId":"NCT01874691",
"OrgStudyIdInfo":{
"OrgStudyId":"2011BAI11B02-A"
},
"SecondaryIdInfoList":{
"SecondaryIdInfo":[
{
"SecondaryId":"2011BAI11B02",
"SecondaryIdType":"Other Grant/Funding Number",
"SecondaryIdDomain":"Chinese Ministry of Science and Technology"
}
]
},
"Organization":{
"OrgFullName":"Chinese Academy of Medical Sciences, Fuwai Hospital",
"OrgClass":"OTHER"
},
"BriefTitle":"China Acute Myocardial Infarction Registry",
"OfficialTitle":"China Acute Myocardial Infarction Registry",
"Acronym":"CAMIRegistry"
},
"StatusModule":{
"StatusVerifiedDate":"May 2022",
"OverallStatus":"Completed",
"ExpandedAccessInfo":{
"HasExpandedAccess":"No"
},
"StartDateStruct":{
"StartDate":"January 2013",
"StartDateType":"Actual"
},
"PrimaryCompletionDateStruct":{
"PrimaryCompletionDate":"December 2016",
"PrimaryCompletionDateType":"Actual"
},
"CompletionDateStruct":{
"CompletionDate":"December 2016",
"CompletionDateType":"Actual"
},
"StudyFirstSubmitDate":"June 4, 2013",
"StudyFirstSubmitQCDate":"June 7, 2013",
"StudyFirstPostDateStruct":{
"StudyFirstPostDate":"June 11, 2013",
"StudyFirstPostDateType":"Estimate"
},
"LastUpdateSubmitDate":"May 7, 2022",
"LastUpdatePostDateStruct":{
"LastUpdatePostDate":"May 12, 2022",
"LastUpdatePostDateType":"Actual"
}
},
"SponsorCollaboratorsModule":{
"ResponsibleParty":{
"ResponsiblePartyType":"Principal Investigator",
"ResponsiblePartyInvestigatorFullName":"Yuejin Yang",
"ResponsiblePartyInvestigatorTitle":"Doctor",
"ResponsiblePartyInvestigatorAffiliation":"Chinese Academy of Medical Sciences, Fuwai Hospital"
},
"LeadSponsor":{
"LeadSponsorName":"Chinese Academy of Medical Sciences, Fuwai Hospital",
"LeadSponsorClass":"OTHER"
}
},
"OversightModule":{
"OversightHasDMC":"Yes"
},
"DescriptionModule":{
"BriefSummary":"This study is to build a Chinese national registry and surveillance system for acute myocardial infarction(AMI) to obtain real-world information about current status of characteristics, risk factors, diagnosis, treatment and outcomes of Chinese AMI patients; And to propose scientific precaution strategies aimed to prevent effectively from the incidence of AMI; And to optimize the management and outcomes of AMI patients through implementation of guideline recommendations in clinical practice, and analysis and development of effective treatment strategies; And to create cost-effective assessment system.",
"DetailedDescription":"The aim of the study is to establish the national platform for surveillance, clinical research and translational medicine in China, designed to facilitate efforts to improve the quality of AMI patient care and thus decrease morbidity and mortality associated with AMI."
},
"ConditionsModule":{
"ConditionList":{
"Condition":[
"Acute Myocardial Infarction"
]
},
"KeywordList":{
"Keyword":[
"acute myocardial infarction",
"China",
"Registry"
]
}
},
"DesignModule":{
"StudyType":"Observational",
"PatientRegistry":"Yes",
"TargetDuration":"2 Years",
"DesignInfo":{
"DesignObservationalModelList":{
"DesignObservationalModel":[
"Case-Only"
]
},
"DesignTimePerspectiveList":{
"DesignTimePerspective":[
"Prospective"
]
}
},
"EnrollmentInfo":{
"EnrollmentCount":"20000",
"EnrollmentType":"Actual"
}
},
"ArmsInterventionsModule":{
"ArmGroupList":{
"ArmGroup":[
{
"ArmGroupLabel":"acute myocardial infarction",
"ArmGroupDescription":"acute myocardial infarction including ST-elevation and non ST-elevation myocardial infarction"
}
]
}
},
"OutcomesModule":{
"PrimaryOutcomeList":{
"PrimaryOutcome":[
{
"PrimaryOutcomeMeasure":"In-hospital mortality of the patients with acute myocardial infarction in different-level hospitals across China",
"PrimaryOutcomeDescription":"Different-level hospitals include Provincial-level, city-level, County-level hospitals from all over China.",
"PrimaryOutcomeTimeFrame":"the duration of hospital stay, an expected average of 2 weeks"
}
]
},
"SecondaryOutcomeList":{
"SecondaryOutcome":[
{
"SecondaryOutcomeMeasure":"The rate of the application of thrombolysis and primary percutaneous coronary intervention for Chinese patients with acute myocardial infarction in different-level hospitals",
"SecondaryOutcomeDescription":"In different-level hospitals, How many patients with acute myocardial infarction receive thrombolysis and/or primary percutaneous coronary intervention within 24 hours from the onset,respectively?",
"SecondaryOutcomeTimeFrame":"24 hours"
},{
"SecondaryOutcomeMeasure":"provoking factors of Chinese patients with AMI across different areas and different population in China",
"SecondaryOutcomeDescription":"The different factors that can provoke the onset of acute myocardial infarction, for example, excess exercise, overload work, heavy smoking, heavy drinking of alcohol and so on.",
"SecondaryOutcomeTimeFrame":"24 hours"
}
]
},
"OtherOutcomeList":{
"OtherOutcome":[
{
"OtherOutcomeMeasure":"the in-hospital cost of Chinese patients with acute myocardial infarction",
"OtherOutcomeTimeFrame":"the duration of hospital stay, an expected average of 2 weeks"
}
]
}
},
"EligibilityModule":{
"EligibilityCriteria":"Inclusion Criteria:Eligible patients must be admitted within 7 days of acute ischemic symptoms and diagnosed acute ST-elevation or non ST-elevation myocardial infarction. Diagnosis criteria must meet Universal Definition for AMI (2012). All participating hospitals are required to enroll consecutive patients with AMI.Exclusion Criteria:Myocardial infarction related to percutaneous coronary intervention and coronary artery bypass grafting.",
"HealthyVolunteers":"No",
"Gender":"All",
"StdAgeList":{
"StdAge":[
"Child",
"Adult",
"Older Adult"
]
},
"StudyPopulation":"Eligible patients admitted within 7 days of acute ischemic symptoms and diagnosed acute ST-elevation or non ST-elevation myocardial infarction.",
"SamplingMethod":"Probability Sample"
},
"ContactsLocationsModule":{
"OverallOfficialList":{
"OverallOfficial":[
{
"OverallOfficialName":"Yuejin Yang, MD.",
"OverallOfficialAffiliation":"Fuwai Hospital, Chinse Academy of Medical Sciences",
"OverallOfficialRole":"Study Chair"
}
]
},
"LocationList":{
"Location":[
{
"LocationFacility":"Fuwai Hospital",
"LocationCity":"Beijing",
"LocationState":"Beijing",
"LocationZip":"100037",
"LocationCountry":"China"
}
]
}
},
"ReferencesModule":{
"ReferenceList":{
"Reference":[
{
"ReferencePMID":"20031882",
"ReferenceType":"background",
"ReferenceCitation":"Peterson ED, Roe MT, Rumsfeld JS, Shaw RE, Brindis RG, Fonarow GC, Cannon CP. A call to ACTION (acute coronary treatment and intervention outcomes network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):491-9. doi: 10.1161/CIRCOUTCOMES.108.847145."
},{
"ReferencePMID":"35784538",
"ReferenceType":"derived",
"ReferenceCitation":"Cui K, Fu R, Yang J, Xu H, Yin D, Song W, Wang H, Zhu C, Feng L, Wang Z, Wang Q, Lu Y, Dou K, Yang Y. Admission Blood Glucose and 2-Year Mortality After Acute Myocardial Infarction in Patients With Different Glucose Metabolism Status: A Prospective, Nationwide, and Multicenter Registry. Front Endocrinol (Lausanne). 2022 Jun 15;13:898384. doi: 10.3389/fendo.2022.898384. eCollection 2022."
},{
"ReferencePMID":"35772392",
"ReferenceType":"derived",
"ReferenceCitation":"Cui K, Fu R, Yang J, Xu H, Yin D, Song W, Wang H, Zhu C, Feng L, Wang Z, Wang Q, Lu Y, Dou K, Yang Y; CAMI Registry Investigators. Stress hyperglycemia ratio and long-term mortality after acute myocardial infarction in patients with and without diabetes: A prospective, nationwide, and multicentre registry. Diabetes Metab Res Rev. 2022 Oct;38(7):e3562. doi: 10.1002/dmrr.3562. Epub 2022 Jul 13."
},{
"ReferencePMID":"34631809",
"ReferenceType":"derived",
"ReferenceCitation":"Shi W, Ni L, Yang J, Fan X, Yu M, Yang H, Yu M, Yang Y; China Acute Myocardial Infarction (CAMI) Registry study group. The Clinical Impact of Proton Pump Inhibitors When Co-Administered With Dual Antiplatelet Therapy in Patients Having Acute Myocardial Infarction With Low Risk of Gastrointestinal Bleeding: Insights From the China Acute Myocardial Infarction Registry. Front Cardiovasc Med. 2021 Sep 22;8:685072. doi: 10.3389/fcvm.2021.685072. eCollection 2021."
},{
"ReferencePMID":"34493500",
"ReferenceType":"derived",
"ReferenceCitation":"Shi W, Fan X, Yang J, Ni L, Su S, Yu M, Yang H, Yu M, Yang Y; China Acute Myocardial Infarction(CAMI) Registry Study Group. In-hospital gastrointestinal bleeding in patients with acute myocardial infarction: incidence, outcomes and risk factors analysis from China Acute Myocardial Infarction Registry. BMJ Open. 2021 Sep 7;11(9):e044117. doi: 10.1136/bmjopen-2020-044117."
},{
"ReferencePMID":"31567475",
"ReferenceType":"derived",
"ReferenceCitation":"Song CX, Fu R, Yang JG, Xu HY, Gao XJ, Wang CY, Zheng Y, Jia SB, Dou KF, Yang YJ; CAMI Registry study group. Angiographic characteristics and in-hospital mortality among patients with ST-segment elevation myocardial infarction presenting without typical chest pain: an analysis of China Acute Myocardial Infarction registry. Chin Med J (Engl). 2019 Oct 5;132(19):2286-2291. doi: 10.1097/CM9.0000000000000432."
},{
"ReferencePMID":"31515430",
"ReferenceType":"derived",
"ReferenceCitation":"Song C, Fu R, Li S, Yang J, Wang Y, Xu H, Gao X, Liu J, Liu Q, Wang C, Dou K, Yang Y. Simple risk score based on the China Acute Myocardial Infarction registry for predicting in-hospital mortality among patients with non-ST-segment elevation myocardial infarction: results of a prospective observational cohort study. BMJ Open. 2019 Sep 12;9(9):e030772. doi: 10.1136/bmjopen-2019-030772."
},{
"ReferencePMID":"31471442",
"ReferenceType":"derived",
"ReferenceCitation":"Song C, Fu R, Dou K, Yang J, Xu H, Gao X, Wang H, Liu S, Fan X, Yang Y. Association between smoking and in-hospital mortality in patients with acute myocardial infarction: results from a prospective, multicentre, observational study in China. BMJ Open. 2019 Aug 30;9(8):e030252. doi: 10.1136/bmjopen-2019-030252."
},{
"ReferencePMID":"31255895",
"ReferenceType":"derived",
"ReferenceCitation":"Leng W, Yang J, Fan X, Sun Y, Xu H, Gao X, Wang Y, Li W, Xu Y, Han Y, Jia S, Zheng Y, Yang Y; behalf CAMI Registry investigators. Contemporary invasive management and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction in China: Findings from China Acute Myocardial Infarction (CAMI) Registry. Am Heart J. 2019 Sep;215:1-11. doi: 10.1016/j.ahj.2019.05.015. Epub 2019 Jun 6."
},{
"ReferencePMID":"30807351",
"ReferenceType":"derived",
"ReferenceCitation":"Fu R, Song CX, Dou KF, Yang JG, Xu HY, Gao XJ, Liu QQ, Xu H, Yang YJ. Differences in symptoms and pre-hospital delay among acute myocardial infarction patients according to ST-segment elevation on electrocardiogram: an analysis of China Acute Myocardial Infarction (CAMI) registry. Chin Med J (Engl). 2019 Mar 5;132(5):519-524. doi: 10.1097/CM9.0000000000000122."
},{
"ReferencePMID":"28052755",
"ReferenceType":"derived",
"ReferenceCitation":"Dai Y, Yang J, Gao Z, Xu H, Sun Y, Wu Y, Gao X, Li W, Wang Y, Gao R, Yang Y; CAMI Registry study group. Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry. BMC Cardiovasc Disord. 2017 Jan 4;17(1):2. doi: 10.1186/s12872-016-0442-9."
},{
"ReferencePMID":"27530939",
"ReferenceType":"derived",
"ReferenceCitation":"Sun H, Yang YJ, Xu HY, Yang JG, Gao XJ, Wu Y, Li W, Wang Y, Liu J, Jin C, Song L; CAMI Registry Study Group. [Survey of medical care resources of acute myocardial infarction in different regions and levels of hospitals in China]. Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Jul 24;44(7):565-9. doi: 10.3760/cma.j.issn.0253-3758.2016.07.003. Chinese."
}
]
}
}
},
"DerivedSection":{
"MiscInfoModule":{
"VersionHolder":"November 18, 2022"
},
"ConditionBrowseModule":{
"ConditionMeshList":{
"ConditionMesh":[
{
"ConditionMeshId":"D000009203",
"ConditionMeshTerm":"Myocardial Infarction"
},{
"ConditionMeshId":"D000007238",
"ConditionMeshTerm":"Infarction"
}
]
},
"ConditionAncestorList":{
"ConditionAncestor":[
{
"ConditionAncestorId":"D000007511",
"ConditionAncestorTerm":"Ischemia"
},{
"ConditionAncestorId":"D000010335",
"ConditionAncestorTerm":"Pathologic Processes"
},{
"ConditionAncestorId":"D000009336",
"ConditionAncestorTerm":"Necrosis"
},{
"ConditionAncestorId":"D000017202",
"ConditionAncestorTerm":"Myocardial Ischemia"
},{
"ConditionAncestorId":"D000006331",
"ConditionAncestorTerm":"Heart Diseases"
},{
"ConditionAncestorId":"D000002318",
"ConditionAncestorTerm":"Cardiovascular Diseases"
},{
"ConditionAncestorId":"D000014652",
"ConditionAncestorTerm":"Vascular Diseases"
}
]
},
"ConditionBrowseLeafList":{
"ConditionBrowseLeaf":[
{
"ConditionBrowseLeafId":"M11307",
"ConditionBrowseLeafName":"Myocardial Infarction",
"ConditionBrowseLeafAsFound":"Myocardial Infarction",
"ConditionBrowseLeafRelevance":"high"
},{
"ConditionBrowseLeafId":"M9434",
"ConditionBrowseLeafName":"Infarction",
"ConditionBrowseLeafAsFound":"Infarction",
"ConditionBrowseLeafRelevance":"high"
},{
"ConditionBrowseLeafId":"M9695",
"ConditionBrowseLeafName":"Ischemia",
"ConditionBrowseLeafRelevance":"low"
},{
"ConditionBrowseLeafId":"M11436",
"ConditionBrowseLeafName":"Necrosis",
"ConditionBrowseLeafRelevance":"low"
},{
"ConditionBrowseLeafId":"M5698",
"ConditionBrowseLeafName":"Coronary Artery Disease",
"ConditionBrowseLeafRelevance":"low"
},{
"ConditionBrowseLeafId":"M18658",
"ConditionBrowseLeafName":"Myocardial Ischemia",
"ConditionBrowseLeafRelevance":"low"
},{
"ConditionBrowseLeafId":"M8571",
"ConditionBrowseLeafName":"Heart Diseases",
"ConditionBrowseLeafRelevance":"low"
},{
"ConditionBrowseLeafId":"M16552",
"ConditionBrowseLeafName":"Vascular Diseases",
"ConditionBrowseLeafRelevance":"low"
},{
"ConditionBrowseLeafId":"T170",
"ConditionBrowseLeafName":"Acute Graft Versus Host Disease",
"ConditionBrowseLeafRelevance":"low"
}
]
},
"ConditionBrowseBranchList":{
"ConditionBrowseBranch":[
{
"ConditionBrowseBranchAbbrev":"BC14",
"ConditionBrowseBranchName":"Heart and Blood Diseases"
},{
"ConditionBrowseBranchAbbrev":"BC23",
"ConditionBrowseBranchName":"Symptoms and General Pathology"
},{
"ConditionBrowseBranchAbbrev":"All",
"ConditionBrowseBranchName":"All Conditions"
},{
"ConditionBrowseBranchAbbrev":"Rare",
"ConditionBrowseBranchName":"Rare Diseases"
}
]
}
}
}
}
}
]
}
}
Software development kits
There are SDKs accessible to help the designing of your project, just email for them and they will be sent. Next use the filter attributes to filter the right output for you and with the full clinical trial studies API output in JSON your platform should be possible to build.
Clinical Trial Studies API pricing
Make contact with the API provider to ask for access to trials and samples of it so that you can play with the data ahead of deciding to purchase the full system access. The test access is limited but will be able to provide you with a decent idea of the full platform.
API pricing
Clinical Trials data is available with the price tag starting monthly from $0 with secure payment.
| Option | Price |
Monthly subscription | From $0/month |
Variable pricing | no |
Free Trial
Free trial is available
Alternative options
Contact the Pharmacology API provider to start receiving comprehensive data for fetching pharmacology information related to drugs purposes easily. This pharmacology API includes a massive volume of Healthcare data inclusive of the full elements you want.
Drug Products API offers external data solutions to create data-oriented products for fetching a list of commercially available products in Canada and the United States that contain the drug use cases. The drug products API is the optimal data tool to directly fetch Healthcare data to your client.
Contact the Drug Prices API provider to start getting precise data for fetching unit drug prices purposes today. The drug prices API is the ideal tool to directly get Healthcare data to your API client.
Drug Classification API returns detailed healthcare marketing, pharmaceutical products comparison and analysis, providing information about drugs on healthcare platforms, healthcare research and more data for advancing apps, online products, tools, programs, market inquiries and much more. This drug classification API includes a massive volume of Healthcare data inclusive of all the details you require.
Clinical Study Fields API by Clinical Trials is here to offer quality and fundemental details required for providing study fields on clinical trials for medicine-related platforms, mobile applications, websites, research and more fields. Clinical Study Fields API serves Healthcare databases to advance fetching values from selected API fields for a large set of clinical trial study records goals to power up companies worldwide.
Menu
